25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

PureTech Health plc
Buy, Hold or Sell?

Let's analyze PureTech Health plc together

I guess you are interested in PureTech Health plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PureTech Health plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about PureTech Health plc

I send you an email if I find something interesting about PureTech Health plc.

1. Quick Overview

1.1. Quick analysis of PureTech Health plc (30 sec.)










1.2. What can you expect buying and holding a share of PureTech Health plc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
6.3%

What is your share worth?

Current worth
$1.14
Expected worth in 1 year
$0.15
How sure are you?
34.4%

+ What do you gain per year?

Total Gains per Share
$-0.99
Return On Investment
-49.0%

For what price can you sell your share?

Current Price per Share
$2.02
Expected price per share
$2.02 - $2.13
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of PureTech Health plc (5 min.)




Live pricePrice per Share (EOD)
$2.02
Intrinsic Value Per Share
$-6.98 - $-8.09
Total Value Per Share
$-5.85 - $-6.95

2.2. Growth of PureTech Health plc (5 min.)




Is PureTech Health plc growing?

Current yearPrevious yearGrowGrow %
How rich?$306.2m$537.9m-$155.6m-40.7%

How much money is PureTech Health plc making?

Current yearPrevious yearGrowGrow %
Making money-$25.8m-$17.7m-$8m-31.2%
Net Profit Margin-18,555.8%-525.1%--

How much money comes from the company's main activities?

2.3. Financial Health of PureTech Health plc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#192 / 952

Most Revenue
#664 / 952

Most Profit
#684 / 952

Most Efficient
#904 / 952
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of PureTech Health plc?

Welcome investor! PureTech Health plc's management wants to use your money to grow the business. In return you get a share of PureTech Health plc.

First you should know what it really means to hold a share of PureTech Health plc. And how you can make/lose money.

Speculation

The Price per Share of PureTech Health plc is $2.02. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of PureTech Health plc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in PureTech Health plc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.14. Based on the TTM, the Book Value Change Per Share is $-0.25 per quarter. Based on the YOY, the Book Value Change Per Share is $0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of PureTech Health plc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.08-3.8%-0.09-4.7%-0.05-2.4%0.031.6%0.020.8%
Usd Book Value Change Per Share0.000.0%-0.25-12.3%0.031.5%0.010.7%0.041.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.2%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%-0.25-12.3%0.041.7%0.010.7%0.041.8%
Usd Price Per Share2.35-2.44-2.83-3.39-2.72-
Price to Earnings Ratio-7.58--7.03--14.77--2.31--3.18-
Price-to-Total Gains Ratio-173.98-40.23--30.65--15.45-
Price to Book Ratio2.07-1.83-1.37-1.81-4.93-
Price-to-Total Gains Ratio-173.98-40.23--30.65--15.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.02
Number of shares495
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.250.01
Usd Total Gains Per Share-0.250.01
Gains per Quarter (495 shares)-122.517.05
Gains per Year (495 shares)-490.0328.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-490-50022718
20-980-99035346
30-1470-148058074
40-1960-19706106102
50-2450-24608133130
60-2940-295010159158
70-3430-344011186186
80-3920-393013212214
90-4410-442015239242
100-4900-491016266270

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%6.014.00.030.0%10.022.00.031.3%10.022.00.031.3%
Book Value Change Per Share0.03.01.00.0%3.06.03.025.0%5.08.07.025.0%11.011.010.034.4%11.011.010.034.4%
Dividend per Share0.00.04.00.0%2.00.010.016.7%2.00.018.010.0%2.00.030.06.3%2.00.030.06.3%
Total Gains per Share0.03.01.00.0%3.06.03.025.0%5.08.07.025.0%11.011.010.034.4%11.011.010.034.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of PureTech Health plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0.2470%0.031-100%0.013-100%0.035-100%
Book Value Per Share--1.1361.402-19%2.076-45%1.963-42%1.417-20%
Current Ratio--3.6795.219-30%4.817-24%3.260+13%2.403+53%
Debt To Asset Ratio--0.4720.406+16%0.232+103%0.347+36%0.477-1%
Debt To Equity Ratio--0.8670.687+26%0.304+185%0.535+62%0.774+12%
Dividend Per Share----0%0.004-100%0.001-100%0.001-100%
Eps---0.077-0.095+22%-0.048-38%0.032-339%0.016-599%
Free Cash Flow Per Share---0.148-0.130-13%-0.235+58%-0.160+8%-0.128-13%
Free Cash Flow To Equity Per Share---0.221-0.186-16%-0.124-44%-0.137-38%-0.087-61%
Gross Profit Margin--1.0001.211-17%1.266-21%1.107-10%1.067-6%
Intrinsic Value_10Y_max---8.088--------
Intrinsic Value_10Y_min---6.985--------
Intrinsic Value_1Y_max---0.756--------
Intrinsic Value_1Y_min---0.742--------
Intrinsic Value_3Y_max---2.313--------
Intrinsic Value_3Y_min---2.207--------
Intrinsic Value_5Y_max---3.920--------
Intrinsic Value_5Y_min---3.635--------
Market Cap483630403.840-31%633423170.178664422727.460-5%738579447.313-14%942529359.414-33%869493517.199-27%
Net Profit Margin---145.045-185.558+28%-5.251-96%-38.363-74%-25.619-82%
Operating Margin---230.549-309.825+34%-17.714-92%-66.228-71%-51.106-78%
Operating Ratio--108.979271.348-60%19.596+456%59.248+84%50.734+115%
Pb Ratio1.779-16%2.0691.828+13%1.371+51%1.814+14%4.927-58%
Pe Ratio-6.520+14%-7.582-7.032-7%-14.769+95%-2.305-70%-3.181-58%
Price Per Share2.020-16%2.3492.442-4%2.830-17%3.393-31%2.719-14%
Price To Free Cash Flow Ratio-3.404+14%-3.958-5.054+28%-3.478-12%-6.128+55%-7.178+81%
Quick Ratio--3.6456.755-46%6.214-41%3.452+6%2.556+43%
Return On Assets---0.036-0.040+12%-0.025-29%0.008-547%0.003-1213%
Return On Equity---0.066-0.066+0%-0.033-49%0.015-544%0.005-1483%
Total Gains Per Share----0.2470%0.035-100%0.014-100%0.036-100%
Usd Book Value--306206000.000382218500.000-20%537914500.000-43%544843100.000-44%389322750.000-21%
Usd Book Value Change Per Share----0.2470%0.031-100%0.013-100%0.035-100%
Usd Book Value Per Share--1.1361.402-19%2.076-45%1.963-42%1.417-20%
Usd Dividend Per Share----0%0.004-100%0.001-100%0.001-100%
Usd Eps---0.077-0.095+22%-0.048-38%0.032-339%0.016-599%
Usd Free Cash Flow---40007000.000-35238272.250-12%-61819446.750+55%-44072206.250+10%-35182878.906-12%
Usd Free Cash Flow Per Share---0.148-0.130-13%-0.235+58%-0.160+8%-0.128-13%
Usd Free Cash Flow To Equity Per Share---0.221-0.186-16%-0.124-44%-0.137-38%-0.087-61%
Usd Market Cap483630403.840-31%633423170.178664422727.460-5%738579447.313-14%942529359.414-33%869493517.199-27%
Usd Price Per Share2.020-16%2.3492.442-4%2.830-17%3.393-31%2.719-14%
Usd Profit---20886500.000-25865179.500+24%-17795267.750-15%6140075.050-440%3736578.156-659%
Usd Revenue--144000.000140217.750+3%4465814.500-97%1251248.750-88%1777592.969-92%
Usd Total Gains Per Share----0.2470%0.035-100%0.014-100%0.036-100%
 EOD+2 -5MRQTTM+11 -18YOY+5 -305Y+7 -2810Y+6 -29

3.3 Fundamental Score

Let's check the fundamental score of PureTech Health plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.520
Price to Book Ratio (EOD)Between0-11.779
Net Profit Margin (MRQ)Greater than0-145.045
Operating Margin (MRQ)Greater than0-230.549
Quick Ratio (MRQ)Greater than13.645
Current Ratio (MRQ)Greater than13.679
Debt to Asset Ratio (MRQ)Less than10.472
Debt to Equity Ratio (MRQ)Less than10.867
Return on Equity (MRQ)Greater than0.15-0.066
Return on Assets (MRQ)Greater than0.05-0.036
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of PureTech Health plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.020
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About PureTech Health plc

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Fundamental data was last updated by Penke on 2024-11-17 00:36:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit PureTech Health plc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare PureTech Health plc to the Biotechnology industry mean.
  • A Net Profit Margin of -14,504.5% means that $-145.05 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PureTech Health plc:

  • The MRQ is -14,504.5%. The company is making a huge loss. -2
  • The TTM is -18,555.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-14,504.5%TTM-18,555.8%+4,051.2%
TTM-18,555.8%YOY-525.1%-18,030.7%
TTM-18,555.8%5Y-3,836.3%-14,719.4%
5Y-3,836.3%10Y-2,561.9%-1,274.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14,504.5%-115.9%-14,388.6%
TTM-18,555.8%-210.8%-18,345.0%
YOY-525.1%-214.5%-310.6%
5Y-3,836.3%-342.2%-3,494.1%
10Y-2,561.9%-464.5%-2,097.4%
4.3.1.2. Return on Assets

Shows how efficient PureTech Health plc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare PureTech Health plc to the Biotechnology industry mean.
  • -3.6% Return on Assets means that PureTech Health plc generated $-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PureTech Health plc:

  • The MRQ is -3.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.6%TTM-4.0%+0.4%
TTM-4.0%YOY-2.5%-1.5%
TTM-4.0%5Y0.8%-4.8%
5Y0.8%10Y0.3%+0.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.6%-11.1%+7.5%
TTM-4.0%-11.7%+7.7%
YOY-2.5%-11.3%+8.8%
5Y0.8%-12.7%+13.5%
10Y0.3%-14.3%+14.6%
4.3.1.3. Return on Equity

Shows how efficient PureTech Health plc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare PureTech Health plc to the Biotechnology industry mean.
  • -6.6% Return on Equity means PureTech Health plc generated $-0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PureTech Health plc:

  • The MRQ is -6.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.6%TTM-6.6%+0.0%
TTM-6.6%YOY-3.3%-3.3%
TTM-6.6%5Y1.5%-8.1%
5Y1.5%10Y0.5%+1.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.6%-14.2%+7.6%
TTM-6.6%-15.8%+9.2%
YOY-3.3%-13.9%+10.6%
5Y1.5%-18.5%+20.0%
10Y0.5%-19.5%+20.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of PureTech Health plc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient PureTech Health plc is operating .

  • Measures how much profit PureTech Health plc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare PureTech Health plc to the Biotechnology industry mean.
  • An Operating Margin of -23,054.9% means the company generated $-230.55  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PureTech Health plc:

  • The MRQ is -23,054.9%. The company is operating very inefficient. -2
  • The TTM is -30,982.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-23,054.9%TTM-30,982.5%+7,927.6%
TTM-30,982.5%YOY-1,771.4%-29,211.0%
TTM-30,982.5%5Y-6,622.8%-24,359.7%
5Y-6,622.8%10Y-5,110.6%-1,512.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-23,054.9%-258.6%-22,796.3%
TTM-30,982.5%-318.3%-30,664.2%
YOY-1,771.4%-224.0%-1,547.4%
5Y-6,622.8%-386.5%-6,236.3%
10Y-5,110.6%-497.6%-4,613.0%
4.3.2.2. Operating Ratio

Measures how efficient PureTech Health plc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 108.98 means that the operating costs are $108.98 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of PureTech Health plc:

  • The MRQ is 108.979. The company is inefficient in keeping operating costs low. -1
  • The TTM is 271.348. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ108.979TTM271.348-162.368
TTM271.348YOY19.596+251.752
TTM271.3485Y59.248+212.099
5Y59.24810Y50.734+8.515
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ108.9792.594+106.385
TTM271.3483.360+267.988
YOY19.5963.299+16.297
5Y59.2484.788+54.460
10Y50.7346.528+44.206
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of PureTech Health plc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if PureTech Health plc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.68 means the company has $3.68 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of PureTech Health plc:

  • The MRQ is 3.679. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.219. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.679TTM5.219-1.540
TTM5.219YOY4.817+0.402
TTM5.2195Y3.260+1.959
5Y3.26010Y2.403+0.856
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6793.658+0.021
TTM5.2193.874+1.345
YOY4.8174.672+0.145
5Y3.2605.960-2.700
10Y2.4036.277-3.874
4.4.3.2. Quick Ratio

Measures if PureTech Health plc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare PureTech Health plc to the Biotechnology industry mean.
  • A Quick Ratio of 3.64 means the company can pay off $3.64 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PureTech Health plc:

  • The MRQ is 3.645. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.755. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.645TTM6.755-3.110
TTM6.755YOY6.214+0.541
TTM6.7555Y3.452+3.303
5Y3.45210Y2.556+0.896
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6453.104+0.541
TTM6.7553.426+3.329
YOY6.2144.498+1.716
5Y3.4525.933-2.481
10Y2.5566.426-3.870
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of PureTech Health plc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of PureTech Health plc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare PureTech Health plc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.47 means that PureTech Health plc assets are financed with 47.2% credit (debt) and the remaining percentage (100% - 47.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PureTech Health plc:

  • The MRQ is 0.472. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.406. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.472TTM0.406+0.066
TTM0.406YOY0.232+0.174
TTM0.4065Y0.347+0.059
5Y0.34710Y0.477-0.130
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4720.354+0.118
TTM0.4060.345+0.061
YOY0.2320.311-0.079
5Y0.3470.366-0.019
10Y0.4770.382+0.095
4.5.4.2. Debt to Equity Ratio

Measures if PureTech Health plc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare PureTech Health plc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 86.7% means that company has $0.87 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PureTech Health plc:

  • The MRQ is 0.867. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.687. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.867TTM0.687+0.179
TTM0.687YOY0.304+0.383
TTM0.6875Y0.535+0.152
5Y0.53510Y0.774-0.239
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8670.398+0.469
TTM0.6870.437+0.250
YOY0.3040.378-0.074
5Y0.5350.452+0.083
10Y0.7740.495+0.279
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings PureTech Health plc generates.

  • Above 15 is considered overpriced but always compare PureTech Health plc to the Biotechnology industry mean.
  • A PE ratio of -7.58 means the investor is paying $-7.58 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PureTech Health plc:

  • The EOD is -6.520. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.582. Based on the earnings, the company is expensive. -2
  • The TTM is -7.032. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.520MRQ-7.582+1.062
MRQ-7.582TTM-7.032-0.550
TTM-7.032YOY-14.769+7.738
TTM-7.0325Y-2.305-4.727
5Y-2.30510Y-3.181+0.876
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.520-2.160-4.360
MRQ-7.582-2.428-5.154
TTM-7.032-3.145-3.887
YOY-14.769-3.304-11.465
5Y-2.305-6.080+3.775
10Y-3.181-6.625+3.444
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of PureTech Health plc:

  • The EOD is -3.404. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.958. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.054. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.404MRQ-3.958+0.554
MRQ-3.958TTM-5.054+1.095
TTM-5.054YOY-3.478-1.576
TTM-5.0545Y-6.128+1.074
5Y-6.12810Y-7.178+1.050
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.404-2.980-0.424
MRQ-3.958-3.295-0.663
TTM-5.054-3.682-1.372
YOY-3.478-4.523+1.045
5Y-6.128-8.162+2.034
10Y-7.178-9.239+2.061
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of PureTech Health plc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.07 means the investor is paying $2.07 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of PureTech Health plc:

  • The EOD is 1.779. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.069. Based on the equity, the company is underpriced. +1
  • The TTM is 1.828. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.779MRQ2.069-0.290
MRQ2.069TTM1.828+0.241
TTM1.828YOY1.371+0.456
TTM1.8285Y1.814+0.014
5Y1.81410Y4.927-3.113
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.7791.869-0.090
MRQ2.0692.027+0.042
TTM1.8282.365-0.537
YOY1.3712.419-1.048
5Y1.8143.668-1.854
10Y4.9274.362+0.565
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Income Tax Expense  11,807-2,4489,3599,65819,017-15,9433,074-9,221-6,147



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets579,950
Total Liabilities273,744
Total Stockholder Equity315,867
 As reported
Total Liabilities 273,744
Total Stockholder Equity+ 315,867
Total Assets = 579,950

Assets

Total Assets579,950
Total Current Assets508,810
Long-term Assets71,140
Total Current Assets
Cash And Cash Equivalents 308,478
Short-term Investments 191,938
Net Receivables 2,055
Other Current Assets 6,339
Total Current Assets  (as reported)508,810
Total Current Assets  (calculated)508,810
+/-0
Long-term Assets
Property Plant Equipment 17,336
Intangible Assets 906
Long-term Assets Other 878
Long-term Assets  (as reported)71,140
Long-term Assets  (calculated)19,120
+/- 52,020

Liabilities & Shareholders' Equity

Total Current Liabilities138,314
Long-term Liabilities135,430
Total Stockholder Equity315,867
Total Current Liabilities
Short-term Debt 10,853
Accounts payable 8,125
Other Current Liabilities 67,066
Total Current Liabilities  (as reported)138,314
Total Current Liabilities  (calculated)86,044
+/- 52,270
Long-term Liabilities
Long-term Liabilities  (as reported)135,430
Long-term Liabilities  (calculated)0
+/- 135,430
Total Stockholder Equity
Common Stock4,860
Retained Earnings 75,996
Accumulated Other Comprehensive Income 130,147
Other Stockholders Equity 104,864
Total Stockholder Equity (as reported)315,867
Total Stockholder Equity (calculated)315,867
+/-0
Other
Cash and Short Term Investments 310,114
Common Stock Shares Outstanding 269,657
Current Deferred Revenue26,135
Liabilities and Stockholders Equity 579,950
Net Debt -163,745
Net Working Capital 370,496
Short Long Term Debt Total 144,733



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-312015-06-302014-12-31
> Total Assets 
228,028
303,492
326,755
313,759
298,749
298,749
269,463
269,463
339,846
339,846
434,875
434,875
441,763
441,763
618,335
618,335
0
941,178
0
1,105,523
0
989,994
989,994
896,883
0
946,006
946,006
823,153
702,647
702,647
702,647
693,552
693,973
693,973
579,950
579,950
579,950579,950693,973693,973693,552702,647702,647702,647823,153946,006946,0060896,883989,994989,99401,105,5230941,1780618,335618,335441,763441,763434,875434,875339,846339,846269,463269,463298,749298,749313,759326,755303,492228,028
   > Total Current Assets 
223,719
296,222
318,202
268,259
288,153
288,153
253,969
253,969
198,109
198,109
209,767
209,767
259,786
259,786
216,108
216,108
168,845
168,845
346,871
346,871
414,348
414,348
414,348
451,057
501,809
501,809
501,809
381,811
386,192
386,192
386,192
360,099
347,201
347,201
508,810
508,810
508,810508,810347,201347,201360,099386,192386,192386,192381,811501,809501,809501,809451,057414,348414,348414,348346,871346,871168,845168,845216,108216,108259,786259,786209,767209,767198,109198,109253,969253,969288,153288,153268,259318,202296,222223,719
       Cash And Cash Equivalents 
218,960
221,303
134,751
71,528
62,959
62,062
70,332
70,332
72,649
72,649
90,074
90,074
117,051
117,051
132,048
132,048
0
132,360
0
340,120
0
403,881
403,881
439,766
0
465,708
465,708
365,910
149,866
149,866
149,866
350,515
191,081
191,081
308,478
308,478
308,478308,478191,081191,081350,515149,866149,866149,866365,910465,708465,7080439,766403,881403,8810340,1200132,3600132,048132,048117,051117,05190,07490,07472,64972,64970,33270,33262,06262,95971,528134,751221,303218,960
       Short-term Investments 
1,173
70,308
179,781
191,610
218,510
218,510
178,089
178,089
116,098
116,098
110,336
110,336
133,828
133,828
72,175
72,175
0
30,088
0
2,124
0
0
0
2,124
0
0
0
2,124
200,229
200,229
200,229
1,624
136,062
136,062
191,938
191,938
191,938191,938136,062136,0621,624200,229200,229200,2292,1240002,1240002,124030,088072,17572,175133,828133,828110,336110,336116,098116,098178,089178,089218,510218,510191,610179,78170,3081,173
       Net Receivables 
0
0
0
0
125
125
5
5
1,797
1,797
3,373
3,373
1,328
1,328
5,964
5,964
2,327
2,327
2,565
2,565
2,939
2,939
3,836
3,836
23,223
23,223
9,315
9,315
12,317
22,478
22,357
2,301
2,376
14,102
2,055
2,055
2,0552,05514,1022,3762,30122,35722,47812,3179,3159,31523,22323,2233,8363,8362,9392,9392,5652,5652,3272,3275,9645,9641,3281,3283,3733,3731,7971,797551251250000
       Other Current Assets 
0
4,611
0
5,121
897
897
0
5,548
927
927
0
9,357
2,199
2,199
0
11,885
2,124
2,124
0
2,062
2,123
-1
-1
9,167
2,123
-1
-1
-1
23,780
-1
-1
5,659
17,682
-1
6,339
6,339
6,3396,339-117,6825,659-1-123,780-1-1-12,1239,167-1-12,1232,06202,1242,12411,88502,1992,1999,35709279275,54808978975,12104,6110
   > Long-term Assets 
4,309
7,270
8,553
45,500
0
10,596
0
15,494
0
141,737
0
225,108
0
181,977
0
402,227
0
772,333
0
758,652
0
575,645
575,645
445,826
0
444,197
444,197
441,341
316,455
316,454
316,454
333,453
346,772
346,771
71,140
71,140
71,14071,140346,771346,772333,453316,454316,454316,455441,341444,197444,1970445,826575,645575,6450758,6520772,3330402,2270181,9770225,1080141,737015,494010,596045,5008,5537,2704,309
       Property Plant Equipment 
1,227
3,163
4,519
6,378
6,924
6,924
6,790
6,790
6,862
6,862
7,583
7,583
8,323
8,323
69,777
69,777
43,838
43,838
43,153
43,154
42,875
42,874
42,874
41,953
43,937
43,936
43,936
41,400
37,238
37,238
37,238
21,497
19,361
19,361
17,336
17,336
17,33617,33619,36119,36121,49737,23837,23837,23841,40043,93643,93643,93741,95342,87442,87442,87543,15443,15343,83843,83869,77769,7778,3238,3237,5837,5836,8626,8626,7906,7906,9246,9246,3784,5193,1631,227
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
000020000000000000000000000000000000
       Long Term Investments 
0
0
0
0
83
83
336
336
131,351
131,351
213,873
213,873
169,755
169,755
324,275
324,275
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000324,275324,275169,755169,755213,873213,873131,351131,35133633683830000
       Intangible Assets 
0
0
3,871
0
3,524
3,524
8,293
8,293
3,309
3,309
3,197
3,197
3,080
3,080
7,593
7,593
0
625
0
625
0
899
899
898
0
987
987
968
831
831
831
931
906
906
906
906
90690690690693183183183196898798708988998990625062507,5937,5933,0803,0803,1973,1973,3093,3098,2938,2933,5243,52403,87100
       Long-term Assets Other 
5
14
57
76
0
65
0
75
0
116,171
0
102,278
0
134,198
0
206,709
0
32,269
0
151
0
531,872
531,872
10
0
399,274
399,274
3,198
846
10
278,385
956
879
878
7,656
878
8787,656878879956278,385108463,198399,274399,274010531,872531,8720151032,2690206,7090134,1980102,2780116,17107506507657145
> Total Liabilities 
94,341
119,763
162,702
187,961
206,338
206,338
236,805
236,805
275,849
275,849
217,816
217,816
274,791
274,791
410,699
410,699
0
290,780
0
338,644
0
336,455
336,455
335,511
0
361,859
361,859
247,129
155,058
155,058
155,058
184,661
235,742
235,742
273,744
273,744
273,744273,744235,742235,742184,661155,058155,058155,058247,129361,859361,8590335,511336,455336,4550338,6440290,7800410,699410,699274,791274,791217,816217,816275,849275,849236,805236,805206,338206,338187,961162,702119,76394,341
   > Total Current Liabilities 
93,673
118,819
160,524
185,751
204,080
204,080
234,475
234,475
273,862
273,862
215,956
215,956
265,764
265,764
312,565
312,565
139,201
139,201
156,039
156,039
180,924
180,924
180,924
213,948
226,135
226,135
226,135
150,254
96,885
96,885
96,885
49,265
51,370
51,370
138,314
138,314
138,314138,31451,37051,37049,26596,88596,88596,885150,254226,135226,135226,135213,948180,924180,924180,924156,039156,039139,201139,201312,565312,565265,764265,764215,956215,956273,862273,862234,475234,475204,080204,080185,751160,524118,81993,673
       Short-term Debt 
6,948
3,329
4,955
5,420
6,953
6,953
7,320
7,320
7,455
7,455
12,437
12,437
0
12,010
0
8,537
0
4,384
0
4,521
0
29,716
29,716
32,150
0
8,723
8,723
9,519
7,501
12,473
12,473
5,580
7,093
7,093
10,853
10,853
10,85310,8537,0937,0935,58012,47312,4737,5019,5198,7238,723032,15029,71629,71604,52104,38408,537012,010012,43712,4377,4557,4557,3207,3206,9536,9535,4204,9553,3296,948
       Short Long Term Debt 
0
0
0
0
6,953
6,953
7,320
7,320
7,455
7,455
12,437
12,437
0
0
0
7,391
0
1,455
0
1,455
0
26,455
0
28,690
0
4,773
0
4,884
0
7,501
0
2,359
0
3,699
0
0
003,69902,35907,50104,88404,773028,690026,45501,45501,45507,39100012,43712,4377,4557,4557,3207,3206,9536,9530000
       Accounts payable 
4,731
10,834
2,393
7,073
2,077
2,077
14,325
14,325
3,394
3,394
12,272
12,272
4,644
4,644
21,539
21,539
11,098
11,098
12,802
12,802
8,871
8,871
8,871
12,024
11,345
11,346
11,346
15,094
26,503
26,504
26,504
8,725
14,636
14,637
8,125
8,125
8,1258,12514,63714,6368,72526,50426,50426,50315,09411,34611,34611,34512,0248,8718,8718,87112,80212,80211,09811,09821,53921,5394,6444,64412,27212,2723,3943,39414,32514,3252,0772,0777,0732,39310,8344,731
       Other Current Liabilities 
11,782
33,440
66,124
84,250
186,006
97,622
212,830
120,018
250,049
121,039
191,247
178,131
237,879
218,307
282,489
247,985
114,975
101,504
138,716
138,716
132,747
142,337
731
154,977
183,455
206,066
174,742
125,622
62,881
27,339
55,723
168
29,641
169
119,336
67,066
67,066119,33616929,64116855,72327,33962,881125,622174,742206,066183,455154,977731142,337132,747138,716138,716101,504114,975247,985282,489218,307237,879178,131191,247121,039250,049120,018212,83097,622186,00684,25066,12433,44011,782
   > Long-term Liabilities 
668
944
2,178
2,210
0
2,258
0
2,330
0
1,987
0
1,860
0
9,027
0
98,134
0
151,579
0
182,605
0
155,531
155,531
121,563
0
135,724
135,724
96,875
58,173
58,173
58,173
135,396
184,372
184,372
135,430
135,430
135,430135,430184,372184,372135,39658,17358,17358,17396,875135,724135,7240121,563155,531155,5310182,6050151,579098,13409,02701,86001,98702,33002,25802,2102,178944668
       Other Liabilities 
0
0
0
0
2,258
2,258
2,330
2,330
1,987
1,987
1,860
1,860
9,027
9,027
42,022
42,022
116,665
116,665
148,670
148,670
108,625
108,625
76,126
76,126
92,423
92,423
58,297
58,297
23,774
23,774
11,674
11,674
0
0
0
0
000011,67411,67423,77423,77458,29758,29792,42392,42376,12676,126108,625108,625148,670148,670116,665116,66542,02242,0229,0279,0271,8601,8601,9871,9872,3302,3302,2582,2580000
> Total Stockholder Equity
179,004
227,403
226,123
201,403
177,666
177,666
137,980
137,980
214,302
214,302
313,331
313,331
275,507
275,507
350,203
350,203
0
668,038
0
783,766
0
669,748
669,748
567,997
0
593,515
593,515
581,757
542,220
542,220
542,220
513,669
464,066
464,066
315,867
315,867
315,867315,867464,066464,066513,669542,220542,220542,220581,757593,515593,5150567,997669,748669,7480783,7660668,0380350,203350,203275,507275,507313,331313,331214,302214,302137,980137,980177,666177,666201,403226,123227,403179,004
   Common Stock
159,362
4,219
4,523
4,576
4,609
4,609
4,655
4,655
4,679
4,679
5,305
5,305
5,375
5,375
5,375
5,375
5,408
5,408
5,411
5,411
5,417
5,417
5,417
5,419
5,444
5,444
5,444
5,446
5,455
5,455
5,455
5,461
5,461
5,461
4,860
4,860
4,8604,8605,4615,4615,4615,4555,4555,4555,4465,4445,4445,4445,4195,4175,4175,4175,4115,4115,4085,4085,3755,3755,3755,3755,3055,3054,6794,6794,6554,6554,6094,6094,5764,5234,219159,362
   Retained Earnings 
-70,421
-80,591
-111,420
-141,524
-160,335
-160,335
-202,294
-202,294
-127,873
-127,873
-127,821
-127,821
-167,692
-167,692
-92,371
-92,371
254,444
254,444
378,400
378,400
260,429
260,429
260,429
185,034
199,871
199,871
199,871
171,527
149,516
149,516
149,516
124,512
83,820
83,820
-62,510
75,996
75,996-62,51083,82083,820124,512149,516149,516149,516171,527199,871199,871199,871185,034260,429260,429260,429378,400378,400254,444254,444-92,371-92,371-167,692-167,692-127,821-127,821-127,873-127,873-202,294-202,294-160,335-160,335-141,524-111,420-80,591-70,421
   Capital Surplus 000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000
   Other Stockholders Equity 
90,063
303,775
333,020
338,351
151,734
333,392
154,007
335,619
155,908
337,496
157,393
435,847
159,439
437,824
158,814
444,391
120,224
408,186
111,730
288,225
114,924
403,902
403,902
377,544
98,897
388,200
388,200
404,784
263,132
387,249
387,249
383,696
245,636
374,785
243,370
104,864
104,864243,370374,785245,636383,696387,249387,249263,132404,784388,200388,20098,897377,544403,902403,902114,924288,225111,730408,186120,224444,391158,814437,824159,439435,847157,393337,496155,908335,619154,007333,392151,734338,351333,020303,77590,063



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,330
Cost of Revenue-4,933
Gross Profit-1,603-1,603
 
Operating Income (+$)
Gross Profit-1,603
Operating Expense-144,597
Operating Income-146,199-146,200
 
Operating Expense (+$)
Research Development96,235
Selling General Administrative25,180
Selling And Marketing Expenses23,182
Operating Expense144,597144,597
 
Net Interest Income (+$)
Interest Income16,012
Interest Expense-13,488
Other Finance Cost-0
Net Interest Income2,524
 
Pretax Income (+$)
Operating Income-146,199
Net Interest Income2,524
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-36,103-256,295
EBIT - interestExpense = -30,048
-35,172
-52,209
Interest Expense13,488
Earnings Before Interest and Taxes (EBIT)-16,560-22,615
Earnings Before Interest and Taxes (EBITDA)-11,627
 
After tax Income (+$)
Income Before Tax-36,103
Tax Provision-30,525
Net Income From Continuing Ops-66,628-66,628
Net Income-65,697
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses149,529
Total Other Income/Expenses Net110,096-2,524
 

Technical Analysis of PureTech Health plc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of PureTech Health plc. The general trend of PureTech Health plc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine PureTech Health plc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of PureTech Health plc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.13 < 2.13 < 2.13.

The bearish price targets are: 2.1 > 2.1 > 2.02.

Tweet this
PureTech Health plc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of PureTech Health plc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

PureTech Health plc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of PureTech Health plc.

PureTech Health plc Daily Moving Average Convergence/Divergence (MACD) ChartPureTech Health plc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of PureTech Health plc. The current adx is .

PureTech Health plc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of PureTech Health plc.

PureTech Health plc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of PureTech Health plc.

PureTech Health plc Daily Relative Strength Index (RSI) ChartPureTech Health plc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of PureTech Health plc.

PureTech Health plc Daily Stochastic Oscillator ChartPureTech Health plc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of PureTech Health plc.

PureTech Health plc Daily Commodity Channel Index (CCI) ChartPureTech Health plc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of PureTech Health plc.

PureTech Health plc Daily Chande Momentum Oscillator (CMO) ChartPureTech Health plc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of PureTech Health plc.

PureTech Health plc Daily Williams %R ChartPureTech Health plc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of PureTech Health plc.

PureTech Health plc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of PureTech Health plc.

PureTech Health plc Daily Average True Range (ATR) ChartPureTech Health plc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of PureTech Health plc.

PureTech Health plc Daily On-Balance Volume (OBV) ChartPureTech Health plc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of PureTech Health plc.

PureTech Health plc Daily Money Flow Index (MFI) ChartPureTech Health plc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for PureTech Health plc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-09BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-11-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

PureTech Health plc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of PureTech Health plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.020
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of PureTech Health plc with someone you think should read this too:
  • Are you bullish or bearish on PureTech Health plc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about PureTech Health plc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about PureTech Health plc

I send you an email if I find something interesting about PureTech Health plc.


Comments

How you think about this?

Leave a comment

Stay informed about PureTech Health plc.

Receive notifications about PureTech Health plc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.